Overview of Redex

Property	Description
Active ingredient	Chlorzoxazone, Diclofenac
Form	Oral Solid Dosage (Tablet)
Pharmacological class	Skeletal Muscle Relaxant, NSAID
General Purpose	Relief from acute muscle spasm and pain
Origin	Synthetic

Redex: Definition and Primary Classification

Redex is a fixed-dose combination medication defined by its dual synthetic composition, which includes the active ingredients Chlorzoxazone and Diclofenac. This oral dosage form, typically a tablet, is classified under two distinct, high-level pharmacological classes: a Skeletal Muscle Relaxant and a Nonsteroidal Anti-inflammatory Drug (NSAID). This product is generally available as a prescription-only medicine (Rx status), signifying its intended use for situations requiring professional assessment.

Composition and Dual Mechanism Type

The formula combines Chlorzoxazone, which acts as a centrally-acting muscle relaxant, with Diclofenac (often as the sodium salt), an agent used for its analgesic and anti-inflammatory properties. This dual composition reflects the intended pharmacological action of addressing both muscle spasm and pain concurrently. While Redex is one specific brand name for this formulation, other equivalent multi-ingredient products may be marketed under different names, such as Parafon Forte, which similarly combines a muscle relaxant with a pain reliever.

General Purpose and Benefit of the Combination

The general purpose of Redex is to alleviate discomfort associated with acute musculoskeletal conditions, such as sudden and painful stiffness following a muscle strain. The benefit arises from the combination's ability to mitigate two key factors: Chlorzoxazone works to reduce the involuntary muscle tension, while Diclofenac simultaneously reduces the pain and swelling caused by tissue injury. This combined approach is utilized for the short-term management of acute pain, targeting both the mechanical rigidity of the muscle and the subsequent inflammatory response.

Regulatory References

Chlorzoxazone: MedlinePlus Drug Information

What side effects are possible with Redex?

Possible Side Effects and Safety Information

The official regulatory documentation for the combination medication Redex (Chlorzoxazone and Diclofenac) outlines potential adverse reactions across multiple physiological systems, reflecting risks associated with both the muscle relaxant and the Nonsteroidal Anti-inflammatory Drug (NSAID) components.

Adverse effects are documented within specific System-Organ Classes. Effects on the Nervous System include drowsiness, dizziness, light-headedness, and general malaise, which an occasional patient may note. Gastrointestinal Disturbances, such as nausea, vomiting, indigestion, and abdominal pain, are commonly listed.

Serious Adverse Reactions

Regulatory documents emphasize the potential for serious adverse events. As with other NSAIDs, there is a documented risk of serious, potentially fatal, Cardiovascular Thrombotic Events (such as myocardial infarction and stroke). Similarly, serious Gastrointestinal Events, including bleeding, ulceration, and perforation of the stomach or intestines, are explicitly noted.

Hepatotoxicity (liver damage) is a concern, with reports of elevated liver enzymes and rare cases of serious hepatic failure. Severe Hypersensitivity Reactions, including anaphylaxis and serious skin conditions like Stevens-Johnson Syndrome (SJS), are also documented in the official safety profile.

Contextual Safety Considerations

The risk of cardiovascular thrombotic events may increase with the duration of use. Safety information for Older Adults notes an increased frequency of adverse reactions, particularly serious gastrointestinal events. Diclofenac is formally contraindicated during the last trimester of pregnancy. Furthermore, caution is advised for patients with existing renal or hepatic impairment. The medication is also contraindicated for perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery and in patients with a history of allergic reactions to other NSAIDs.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented overdose profile and emergency actions for Redex (Chlorzoxazone and Diclofenac), based strictly on government regulatory documents.

Documented Manifestations and Severe Outcomes

Official labeling describes overdose presentations primarily affecting the gastrointestinal tract and central nervous system. Early signs can include nausea, vomiting, diarrhea, headache, and drowsiness. The muscle relaxant component may lead to marked loss of muscle tone and decreased or absent deep tendon reflexes, though the sensorium generally remains intact.

Severe outcomes are documented, underscoring the seriousness of acute overexposure. These include serious effects such as respiratory depression and hypotension (low blood pressure). For the Diclofenac component, severe complications may extend to acute renal failure, hepatic failure, and pancreatitis.

Immediate Emergency Action and Management

Immediate emergency medical attention must be sought for any suspected overdose event.

Treatment is formally defined as entirely supportive, as no specific antidote is documented for this combination. Official procedural steps include techniques like gastric lavage or the administration of activated charcoal to reduce absorption. Supportive care is required to manage serious outcomes, such as providing oxygen and artificial respiration for depressed breathing, and administering vasopressor agents to counteract hypotension.

Therapeutic Uses of Redex

What Redex Treats: Main Uses and Benefits

Managing Acute Musculoskeletal Spasm and Pain

This medication is relevant in clinical settings that involve acute musculoskeletal conditions marked by sudden, temporary symptom escalation, such as severe muscle strains and sprains. It is specifically used to provide symptomatic relief for conditions that involve a painful symptom cluster where involuntary muscular rigidity coexists with localized inflammatory pain and symptoms related to inflammatory or irritative states. This dual therapeutic focus is commonly used to help ease the overall symptom burden and contributes to improved comfort during periods of heightened symptoms.

The primary indications for use include painful episodes of low back pain, torticollis (stiff neck), and muscle pain associated with physical trauma.

“This medication is applied in scenarios where additional management of discomfort is required, and is considered relevant when symptoms become temporarily overwhelming.”

Symptomatic Relief in Real-World Injury Scenarios

Redex is generally applied in contexts where pronounced, acute symptoms create symptoms that interfere with daily functioning. It is used to help manage distressing manifestations, offering supportive relief in situations where acute manifestations interfere with function. This supportive relief may assist with maintaining functional stability when symptoms become difficult to tolerate.

Quick Fact: Symptomatic Support Focus
Target Domains: Symptoms of increased neurological or muscular activity and symptoms related to inflammatory or irritative states
Therapeutic Aim: Used in areas where short-term symptom management is appropriate

Regulatory References

NIH MedlinePlus overview of Chlorzoxazone

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility Status

Official government regulatory bodies have not provided a standardized, globally accessible Prescribing Information or Summary of Product Characteristics (SmPC) for a product specifically named Redex. Therefore, the established eligibility profile is based on the active pharmaceutical ingredient, Tadalafil, which is commonly associated with this brand name.

Populations Who MUST NOT Use This Medicine

Regulatory documents for Tadalafil (the associated ingredient) define absolute contraindications. Use is strictly prohibited for individuals who:

Have a known hypersensitivity or allergic reaction to Tadalafil or any excipients in the formulation.
Are concurrently using any form of organic nitrate drug (e.g., nitroglycerin, isosorbide dinitrate), as this combination can cause a life-threatening drop in blood pressure.
Are using a guanylate cyclase stimulator such as riociguat.

Populations Requiring Restrictions or Special Consideration

Category	Regulatory Status (Tadalafil-based)
Age-Related	Use not established in the pediatric population (under 18 years old). Older adults may require special consideration due to increased sensitivity.
Organ Function	Use is not recommended in patients with severe hepatic impairment (Child-Pugh Class C). Caution and potential dosage adjustment are required for moderate renal or hepatic impairment.
Physiological State	Use in pregnancy or lactation is generally not recommended unless the potential benefit justifies the potential risk, as safety data is limited.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

This section summarizes the officially documented interactions for the active components of Redex, Diclofenac (an NSAID) and Chlorzoxazone (a Skeletal Muscle Relaxant), based strictly on regulatory prescribing information.

Contraindicated Combinations and Major Restrictions

Diclofenac is officially contraindicated for the treatment of pain in the setting of coronary artery bypass graft (CABG) surgery.
Co-administration with analgesic aspirin or other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) is generally not recommended by regulators due to an increased risk of serious gastrointestinal events.

Pharmacokinetic and Pharmacodynamic Interactions

Interacting Product Category	Official Interaction Statement	Constraint and Monitoring
CNS Depressants & Alcohol	Chlorzoxazone exhibits an additive CNS depressant effect when taken with alcohol, sedatives, or tranquilizers.	Use requires caution due to potential additive effects.
Anticoagulants/Antiplatelets	Diclofenac can increase the risk of bleeding when used with agents like Warfarin or SSRIs/SNRIs due to interference with hemostasis.	Monitoring for signs of bleeding is required.
Antihypertensives & Diuretics	Diclofenac may diminish the therapeutic effect of agents like ACE Inhibitors, ARBs, or Diuretics.	Blood pressure monitoring is required.
Specific Drugs Increasing Exposure	Substances like Voriconazole are documented to significantly increase the plasma concentration (AUC and C max) of Diclofenac.	Monitoring of drug levels is required (e.g., Digoxin, Lithium).

Population-Specific Interaction Notes

Official labeling notes that the risk of worsened renal function when Diclofenac is combined with ACE Inhibitors or ARBs is a particular concern in elderly or volume-depleted patients, necessitating specific monitoring of renal status in these populations.

Mechanism of Action

How Redex Works

Redex functions as an inhibitor of the Cathepsin K enzyme, a lysosomal cysteine protease found predominantly within osteoclasts. The compound demonstrates selective binding to the active site of Cathepsin K. This molecular interaction blocks the enzyme's hydrolytic activity, which is necessary for the degradation of bone matrix proteins, primarily Type I collagen.

This specific inhibition results in the functional inactivation of Cathepsin K activity within the osteoclast resorption pit. By preventing the enzymatic breakdown of the organic bone matrix, Redex modulates the overall rate of osteoclast-mediated bone resorption.

The resulting pharmacological effect is a reduction in the destructive phase of the bone remodeling cycle. This cellular modulation facilitates a net shift in the systemic balance between bone formation and bone resorption at the tissue level.

Dosage and Administration Information

How to Use Redex: Standardized Administration

Redex administration involves specific protocols to ensure standardized use. The medicine is available in two forms: an injectable solution for intravenous (IV) infusion, typically administered in a clinical setting, and an oral, film-coated tablet for use at home. Following the instructions for dose, frequency, and preparation is required for the intended use of the medication.

Dosing and Administration Routes

Administration Scope	Details
Route of Administration	Intravenous (IV) or Oral
Dosing Schedule	IV: 100 mg/m² on Day 1 of a 21-day cycle; Oral: 25 mg once daily.
Timing Relative to Meals	Oral tablets may be taken with or without food.

Preparation and Special Conditions

For the IV form, the concentrated solution must be diluted immediately prior to use. Instructions specify dilution in 250 mL of 0.9% Sodium Chloride or 5% Dextrose. The resulting solution is administered via IV infusion over a period of 60 minutes.

Oral tablets must be swallowed whole; instructions prohibit crushing, chewing, or breaking the tablet. If an oral dose is missed by more than 12 hours, the dose should be skipped, and the regular dosing schedule resumed. Dosage adjustments are utilized for specific patient populations, such as a 25% reduction for patients with moderate renal impairment. These instructions define the protocol for using Redex.

Recent Clinical Evidence

Research evidence / Overview of studies for Redex

Conditions characterized by fluctuating or episodic manifestations

Research relevant to the drug classes found in Redex (NSAIDs and muscle relaxants) was studied for how symptoms change over time. These studies primarily involved short-term Randomized Controlled Trials (RCTs) and systematic reviews, which compared the combination or similar products against placebo or single-ingredient therapies. The research was applied in contexts involving fluctuating or unstable symptoms. The outcomes monitored included patient-reported outcomes describing perceived discomfort and outcomes related to daily functioning or activity level.

Studies monitored measurements of outcomes related to physical discomfort. Findings describe patterns observed in the studies. The evidence remains limited, and findings were mixed across different study groups, meaning the certainty remains low.

Conditions associated with acute or disruptive episodes

In research scenarios focusing on conditions associated with acute or disruptive episodes, studies were applied in contexts relevant to trials assessing short-term or episodic symptom patterns. These studies included comparative trials which examined the combination or its drug classes against other study arms. This research examined outcomes capturing phases of heightened symptom activity, as well as outcomes related to physiological strain or stress. The studies monitored outcomes linked to inflammatory or irritative states during episodes where symptoms become more noticeable.

Evidence suggests changes were observed in outcomes describing the short-term change in the study populations. Research explored short-term changes that were observed. While the data show patterns related to these acute outcomes, the certainty remains low.

General Research Gaps and Limitations

There is limited information for long-term outcomes in this context, and follow-up durations were limited to the short-term. Sample sizes were often modest, and comparative evidence for the specific fixed-dose combination (FDC) is still evolving. Research does not determine whether an individual will respond similarly to the patterns observed in the studies.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Redex (FAQ)

Q: Is Redex a type of antibiotic or something else?

A: Redex is a combination prescription medicine that contains a Skeletal Muscle Relaxant (Chlorzoxazone) and a Nonsteroidal Anti-inflammatory Drug (NSAID, Diclofenac). It is classified under these two drug classes and is not an antibiotic.

Q: How quickly should I expect to feel the effects of Redex?

A: According to the official product information for the muscle relaxant component, the drug can be found in the bloodstream within 30 minutes. The medicine typically reaches its peak concentration in the body about 1 to 2 hours after taking the oral dose.

Q: Does Redex need to be taken every day or only as needed?

A: Official information indicates that Redex is intended for the short-term management of acute musculoskeletal conditions. It is not typically prescribed for long-term or chronic use.

Q: Is it normal to feel a bit nauseous when first starting Redex?

A: Nausea, vomiting, indigestion, and abdominal pain are listed as common Gastrointestinal Disturbances in the official safety profile. These side effects are reported in association with the NSAID component of the medication.

Q: Does Redex cause drowsiness or affect my ability to drive?

A: The muscle relaxant component of Redex may cause side effects such as drowsiness, dizziness, or light-headedness. Official warnings note that performance of tasks requiring mental alertness, such as driving or operating machinery, may be impaired due to these effects.

Q: Can Redex be used by children or teenagers?

A: Regulatory information for the associated active ingredient (Tadalafil) states that its safety and effectiveness have not been established in the pediatric population, which includes individuals under 18 years of age.

Q: What happens if I accidentally miss a dose of Redex?

A: Official instructions specify that for the oral tablet, if a dose is missed by more than 12 hours, the missed dose is to be skipped entirely. The patient should then resume the regular dosing schedule at the next planned time.

Q: Is Redex considered a long-term or short-term treatment?

A: Redex is generally indicated for the short-term management of acute musculoskeletal pain and spasm. It is not typically prescribed for chronic or long-term conditions.

Q: What kind of research or studies support the use of Redex?

A: Research consists mainly of short-term controlled trials on the drug classes, showing patterns related to reduced discomfort and improved function in acute situations. However, the official regulatory analysis indicates that the certainty of this evidence remains low, and findings have been mixed.

Q: What's the difference between Redex and other similar-sounding medications?

A: Redex is a specific brand name for a fixed-dose combination product containing Chlorzoxazone and Diclofenac. Other multi-ingredient products may exist under different brand names that contain similar combinations of a muscle relaxant and a pain reliever.

Q: What are the typical on-set and peak times for Redex's action?

A: Pharmacology data for the muscle relaxant component (Chlorzoxazone) shows that the medication begins to act quickly. The peak concentration in the blood is typically reached in about 1 to 2 hours after oral administration.

Q: Is Redex a brand name or a generic name?

A: Redex is a brand name used to market a fixed-dose combination of the active ingredients, Chlorzoxazone and Diclofenac.

Q: What should I do if the side effects from Redex feel too strong?

A: The official safety profile for Redex documents the potential for serious adverse reactions, including Cardiovascular Thrombotic Events and severe Gastrointestinal events. Patients who experience symptoms of a serious adverse event are advised to seek medical help promptly.

Q: Are there any specific dietary restrictions while taking Redex?

A: Regulatory labeling notes that the muscle relaxant component (Chlorzoxazone) has an additive depressant effect when combined with alcohol. Due to this potential interaction, regulatory information indicates that alcohol use requires caution while taking Redex.

Q: What are the signs that Redex might be working as intended?

A: Redex is designed to relieve acute musculoskeletal discomfort by mitigating both muscle tension and pain. Signs that the medicine is working as intended include a reduction in involuntary muscle stiffness, localized pain, and associated swelling.

Q: Do I need a specialist to prescribe Redex, or can my family doctor?

A: Redex is categorized as a prescription-only (Rx status) medicine. This means it requires a professional assessment and prescription from a licensed healthcare provider, which can include a family doctor.

Q: Does Redex affect liver function?

A: Yes, official safety information notes a concern for hepatotoxicity (liver damage), with reports of elevated liver enzymes. Regulatory documents indicate that use of Redex is not recommended for patients with severe liver impairment, and caution is required when prescribing it to patients with moderate liver impairment.

Q: Can taking Redex make me more sensitive to the sun?

A: The Nonsteroidal Anti-inflammatory Drug (NSAID) component of Redex may increase your skin's sensitivity to sunlight, a condition known as photosensitivity. Official warnings note that patients taking this medication should limit sun exposure.

Q: Does the time of day matter when I take Redex?

A: The official administration guidelines for the oral tablet state that Redex may be taken with or without food. There is no specific instruction noted in the guidelines regarding a particular time of day for dosing.

Q: Why do doctors recommend Redex for this specific condition?

A: Doctors recommend Redex because its dual action addresses the two primary sources of discomfort in acute muscle injury: the muscle relaxant works to reduce involuntary stiffness, and the NSAID works simultaneously to relieve pain and reduce inflammation.

Q: Are there specific warnings for people with lung conditions taking Redex?

A: The NSAID component of Redex is contraindicated (should not be used) in patients who have a history of allergic reactions to other NSAIDs. This includes patients with a known intolerance to these types of medications.

Q: How reliable is the latest research on Redex?

A: Official regulatory analysis states that the available research evidence supporting the use of the drug classes in this context remains limited. Findings from studies were often mixed, leading the authorities to conclude that the certainty of the evidence remains low.

Q: Is Redex generally considered a safe medication?

A: While Redex is an authorized prescription medicine, its official safety profile documents potential serious risks, including the risk of Cardiovascular Thrombotic Events, serious Gastrointestinal (GI) Bleeding, and Hepatotoxicity. These risks must be assessed relative to the intended short-term benefits.

How should Redex be stored and disposed of?

How to Store and Dispose of Redex

Official regulatory documents define strict requirements for storing, handling, and disposing of this medicine (Fluorouracil 5% Cream).

Labeled Storage and Stability

The medicine must be kept in its original container and stored at a temperature not exceeding 30 C (86 F). The unopened product maintains a shelf life of 60 months.

After the initial opening of the tube, the cream is only stable for a period of 90 days and must be discarded thereafter to ensure product integrity.

Handling and Disposal Requirements

Strict handling precautions are mandated: users must wash hands carefully immediately after applying the cream and must avoid contact with the eyes or mucous membranes. The medicine must not be diluted.

For disposal, any unused product or associated waste material must be handled and disposed of in accordance with local requirements and is prohibited from being discarded in standard trash or flushed down a toilet.

Redex